Hoey Investments Inc. Has $1.40 Million Stock Holdings in iShares Biotechnology ETF $IBB

Hoey Investments Inc. raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 83.3% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 8,263 shares of the financial services provider’s stock after acquiring an additional 3,755 shares during the period. iShares Biotechnology ETF makes up about 0.2% of Hoey Investments Inc.’s holdings, making the stock its 26th largest position. Hoey Investments Inc.’s holdings in iShares Biotechnology ETF were worth $1,395,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Citigroup Inc. grew its position in iShares Biotechnology ETF by 40.9% in the 4th quarter. Citigroup Inc. now owns 5,242,688 shares of the financial services provider’s stock valued at $884,808,000 after purchasing an additional 1,521,992 shares during the period. Morgan Stanley lifted its stake in shares of iShares Biotechnology ETF by 2.5% in the fourth quarter. Morgan Stanley now owns 3,204,126 shares of the financial services provider’s stock valued at $540,760,000 after buying an additional 76,978 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in shares of iShares Biotechnology ETF by 11.4% in the fourth quarter. BNP Paribas Financial Markets now owns 2,133,461 shares of the financial services provider’s stock valued at $360,064,000 after buying an additional 218,066 shares in the last quarter. Raymond James Financial Inc. grew its holdings in shares of iShares Biotechnology ETF by 286.2% during the fourth quarter. Raymond James Financial Inc. now owns 994,311 shares of the financial services provider’s stock valued at $167,810,000 after buying an additional 736,881 shares during the last quarter. Finally, LPL Financial LLC grew its holdings in shares of iShares Biotechnology ETF by 145.9% during the fourth quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock valued at $167,555,000 after buying an additional 589,033 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $196.83 on Tuesday. iShares Biotechnology ETF has a one year low of $128.06 and a one year high of $198.13. The firm has a 50-day moving average of $173.66 and a 200-day moving average of $172.05.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. This represents a $0.10 dividend on an annualized basis and a yield of 0.0%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.